Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Pasithea Therapeutics Corp/
Recent news which mentions Pasithea Therapeutics Corp/
A New BioTech Research Race Is Focused On Improving Life For MS Patients
October 27, 2022
Tickers
AZN
JNJ
MRNA
Tags
Pasithea Therapeutics Corp/
XNAS:KTTA
From
TheNewswire.com - RSS (Media)
A New BioTech Research Race Is Focused On Improving Life For MS Patients
October 27, 2022
Tickers
AZN
BNTX
JNJ
KTTA
Tags
BNTX
Pasithea Therapeutics Corp/
MRNA
From
Benzinga
New Drugs And Therapies Are Giving MS And ALS Sufferers New Hope
October 10, 2022
Tickers
CLNN
KTTA
MRK
Tags
XNAS:KTTA
Pasithea Therapeutics Corp/
From
TheNewswire.com - RSS (Media)
New Drugs And Therapies Are Giving MS And ALS Sufferers New Hope
October 10, 2022
Tickers
CLNN
KTTA
MRK
Tags
General
KTTA
Partner Content
From
Benzinga
Biotech Company Pleased With Results Of Early Testing Demonstrating Vaccine Potential For Multiple Sclerosis
October 03, 2022
Tickers
AZN
JNJ
KTTA
MRNA
Tags
Pasithea Therapeutics Corp/
XNAS:KTTA
From
TheNewswire.com - RSS (Media)
Biotech Company Pleased With Results Of Early Testing Demonstrating Vaccine Potential For Multiple Sclerosis
October 03, 2022
Tickers
AZN
JNJ
KTTA
MRNA
Tags
Biotech
AZN
MRNA
From
Benzinga
Smaller Biotechs May Pave Way For New Generation Of Therapeutics For Hard-to-Treat Neurological Disorders
August 08, 2022
Tickers
AZN
EVO
KTTA
MRK
Tags
MRK
Market News
Tech
From
Benzinga
A Monoclonal Antibody Treatment For ALS Could Begin Human Trials By 2023, According To Pasithea
July 28, 2022
Tickers
BIIB
KTTA
SNY
Tags
Pasithea Therapeutics Corp/
BIIB
General
From
Benzinga
Pasithea Therapeutics Receives AUD $1 Million Research Award Following Recent Acquisition
July 18, 2022
Tickers
KTTA
Tags
Benzinga
Penny Stocks
Market News
From
Benzinga
Pasithea Therapeutics Awarded A Drug Development Research Grant
July 14, 2022
Tickers
KTTA
Tags
Partner Content
Press Releases
Biotech
From
Benzinga
Pasithea Reveals Cash Position Of $52.9 Million In Latest Earnings Report, To Expand Pipeline And Fund Operations Well Into 2024
April 01, 2022
Tickers
KTTA
Tags
Biotech
News
Partner Content
From
Benzinga
Pasithea Partners With Glimpse Group To Co-Develop VR Environments For Patients With Psychiatric Disorders
March 10, 2022
Tickers
KTTA
VRAR
Tags
Market News
Penny Stocks
Benzinga
From
Benzinga
Pasithea Therapeutics Announces Plans To Open Three New Clinics In The UK By Mid-2022
February 24, 2022
Tickers
KTTA
Tags
Pasithea Therapeutics Corp/
General
KTTA
From
Benzinga
From Mobile Clinics to Drug Development, This Company Is Attempting to Tackle Brain Disorders and Promote Mental Health Advances
January 05, 2022
Tickers
ABVC
ANIP
EVO
KTTA
Tags
Market News
Penny Stocks
Benzinga
From
Benzinga
EXCLUSIVE: Pasithea Clinics Launches In-Home Intravenous Ketamine Therapy In Major US Cities
November 17, 2021
Tickers
KTTA
Tags
Market News
Ketamine Therapy
Cannabis
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.